Astrana Health, Inc.
ASTH Healthcare Medical Care Facilities
Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow ASTH
Astrana Health, Inc. (ASTH) EV/Sales
As of 16 October 2026, Astrana Health, Inc. (ASTH) trades at a EV/Sales of 0.6×. Over the past ten years it has ranged from 0.0× (December 2017) to 6.8× (November 2021); the current reading is higher than 31% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.6× | (29.07%) |
| FY2024 | 0.8× | (37.24%) |
| FY2023 | 1.3× | 24.79% |
| FY2022 | 1.0× | (74.35%) |
| FY2021 | 4.0× | 327.61% |
| FY2020 | 0.9× | (20.10%) |
| FY2019 | 1.2× | 9.80% |
| FY2018 | 1.1× | (17.42%) |
| FY2017 | 1.3× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.7× | 47.82% |
| Mar 2026 | 0.5× | (13.72%) |
| Dec 2025 | 0.6× | (16.08%) |
| Sep 2025 | 0.7× | 27.79% |
| 34 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. compare | 0.2× |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.6× |
| ASTH Astrana Health, Inc. | 0.6× |
| MD Pediatrix Medical Group, Inc. compare | 1.2× |
| ADUS Addus HomeCare Corporation compare | 1.4× |
| SGRY Surgery Partners, Inc. compare | 1.6× |
| SNDA Sonida Senior Living, Inc. compare | 6.0× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)